These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 23102533

  • 1. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure.
    Chua HR, Baldwin I, Bailey M, Subramaniam A, Bellomo R.
    J Crit Care; 2012 Dec; 27(6):744.e7-15. PubMed ID: 23102533
    [Abstract] [Full Text] [Related]

  • 2. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Dec; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 3. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.
    Holt AW, Bierer P, Glover P, Plummer JL, Bersten AD.
    Intensive Care Med; 2002 Nov; 28(11):1649-55. PubMed ID: 12415456
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
    Nagarik AP, Soni SS, Adikey GK, Raman A.
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
    [Abstract] [Full Text] [Related]

  • 5. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?
    Agarwal B, Shaw S, Shankar Hari M, Burroughs AK, Davenport A.
    J Hepatol; 2009 Sep; 51(3):504-9. PubMed ID: 19615775
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of nafamostat mesylate in continuous renal replacement therapy among patients at high risk of bleeding.
    Baek NN, Jang HR, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE.
    Ren Fail; 2012 Sep; 34(3):279-85. PubMed ID: 22251267
    [Abstract] [Full Text] [Related]

  • 8. Renal replacement therapy and anticoagulation.
    Brandenburger T, Dimski T, Slowinski T, Kindgen-Milles D.
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE.
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 14. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z, Ni H, Lu B.
    ASAIO J; 2012 Jun; 58(1):46-50. PubMed ID: 22210650
    [Abstract] [Full Text] [Related]

  • 15. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
    Gainza FJ, Quintanilla N, Pijoan JI, Delgado S, Urbizu JM, Lampreabe I.
    J Nephrol; 2006 Jun; 19(5):648-55. PubMed ID: 17136695
    [Abstract] [Full Text] [Related]

  • 16. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW.
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of saline flush to prevent filter clotting in continuous renal replacement therapy without anticoagulant.
    Panphanpho S, Naowapanich S, Ratanarat R.
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S105-10. PubMed ID: 21721435
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the Niagara and Medcomp catheters for continuous renal replacement therapy.
    Fealy N, Kim I, Baldwin I, Schneider A, Bellomo R.
    Ren Fail; 2013 Feb; 35(3):308-13. PubMed ID: 23356529
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
    De Vico P, Messino V, Tartaglione A, Beccaris C, Buonomo C, Talarico D, Prati P, Sabato AF, Colella DF.
    Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.